Business Context and Reporting Period
Company: DocGo Inc. (DCGO)
Filing Type: Form 10-K (Annual Report)
Period Ended: December 31, 2025
Business Overview: DocGo operates a vertically integrated mobile healthcare platform providing Mobile Health Services (in-home care, virtual care) and Transportation Services (ambulance, non-emergency transport) in the U.S. and U.K. The company serves municipalities, hospital networks, and health insurance providers.
Key Financial Metrics (Year Ended Dec 31, 2025)
| Metric | 2025 Value | 2024 Value | Change |
|---|---|---|---|
| Net Revenue | $322.2 million | $616.6 million | (47.7%) |
| Net Loss | $(196.4) million | $13.4 million (Income) | Significant Deterioration |
| Operating Loss | $(178.0) million | $28.7 million (Income) | (720.2%) |
| Operating Cash Flow | $34.5 million | $70.1 million | (50.8%) |
| Cash & Equivalents | $51.0 million | $89.2 million | (42.8%) |
| Working Capital | $84.9 million | $182.7 million | (53.5%) |
| Debt (Revolving Facility) | $0 outstanding | $30.0 million outstanding | Repaid |
Segment Performance:
- Mobile Health Services: Revenue $121.4 million (down 71.3% YoY) due to the wind-down of migrant-related government contracts.
- Transportation Services: Revenue $200.8 million (up 3.8% YoY) driven by a 4.4% increase in trip volumes.
Material Changes vs. Prior Period
- Revenue Decline: Total revenue dropped nearly 48% primarily due to the completion of large-scale migrant-related service contracts in New York that ended in late 2024 and early 2025.
- Significant Impairments: The company recorded non-cash impairment charges totaling approximately $88.8 million, including $58.2 million in goodwill impairment and $30.6 million in intangible asset impairment. These were triggered by sustained revenue reductions and a decline in market capitalization.
- Profitability Reversal: The company swung from a net income of $13.4 million in 2024 to a net loss of $196.4 million in 2025.
- Customer Concentration: One customer accounted for approximately 33% of total revenues in 2025, compared to two customers accounting for 38% and 28% in 2024.
Guidance, Outlook, Risks, and Contingencies
Liquidity and Going Concern:
- The independent auditor included an explanatory paragraph regarding "substantial doubt" about the company's ability to continue as a going concern due to operating losses and covenant non-compliance.
- Management asserts this doubt is alleviated by plans to reduce costs, transition bonuses to stock, and intensify collections on municipal receivables.
- Covenant Breach: As of December 31, 2025, the company was not in compliance with the minimum liquidity financial covenant of its $55 million Revolving Credit Facility. Management is in active discussions with lenders to resolve this.
Nasdaq Listing Status:
- On January 26, 2026, DocGo received notice from Nasdaq regarding non-compliance with the $1.00 minimum bid price requirement.
- The company has 180 days (until July 27, 2026) to regain compliance or risk delisting.
Legal and Regulatory Risks:
- Settlements: A securities class action settlement of $12.5 million (covered by insurance) received preliminary approval. A cybersecurity class action settlement of approximately $337,000 was finalized.
- Regulatory Scrutiny: The company faces risks related to government audits, False Claims Act liability, and compliance with healthcare regulations (HIPAA, Stark Law, Anti-Kickback Statute).
Outlook: Management expects Mobile Health Services revenues to be lower in 2026 than 2025 due to the absence of migrant project revenues, though they anticipate growth in other business lines.
Investor Verification Checklist
- Covenant Resolution: Verify the outcome of discussions with lenders regarding the liquidity covenant breach and the availability of the $55 million credit facility.
- Going Concern Plan Execution: Monitor the effectiveness of cost-cutting measures and the collection of outstanding municipal receivables to ensure liquidity sufficiency.
- Nasdaq Compliance: Track the stock price to determine if the company will meet the $1.00 minimum bid requirement by July 2026 or if a reverse stock split is required.
- Customer Concentration: Assess the stability of the single customer representing 33% of revenue and the risk of contract non-renewal.
- Impairment Recurrence: Evaluate whether further goodwill or intangible asset impairments are likely given the current market capitalization and revenue trajectory.